118 related articles for article (PubMed ID: 28753749)
21. Positive surgical margins in renal cell carcinoma: translating tumor biology into clinical outcomes.
Picken MM; Wang L; Gupta GN
Am J Clin Pathol; 2015 May; 143(5):620-2. PubMed ID: 25873493
[No Abstract] [Full Text] [Related]
22. Renal-type clear cell carcinoma of the prostate: a diagnostic challenge.
Patne SC; Johri N; Katiyar R; Trivedi S; Dwivedi US
Diagn Pathol; 2015 Oct; 10():193. PubMed ID: 26498435
[TBL] [Abstract][Full Text] [Related]
23. KDM5C is overexpressed in prostate cancer and is a prognostic marker for prostate-specific antigen-relapse following radical prostatectomy.
Stein J; Majores M; Rohde M; Lim S; Schneider S; Krappe E; Ellinger J; Dietel M; Stephan C; Jung K; Perner S; Kristiansen G; Kirfel J
Am J Pathol; 2014 Sep; 184(9):2430-7. PubMed ID: 25016185
[TBL] [Abstract][Full Text] [Related]
24. Resection of local recurrence of renal cell carcinoma in a hemodialysis patient 6 years after radical nephrectomy.
Irie K; Ishizuka O; Yokoyama H; Kinebuchi Y; Satoh T; Nishizawa O
Int J Urol; 2004 Jul; 11(7):550-2. PubMed ID: 15242367
[TBL] [Abstract][Full Text] [Related]
25. A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies.
Rini B; Goddard A; Knezevic D; Maddala T; Zhou M; Aydin H; Campbell S; Elson P; Koscielny S; Lopatin M; Svedman C; Martini JF; Williams JA; Verkarre V; Radulescu C; Neuzillet Y; Hemmerlé I; Timsit MO; Tsiatis AC; Bonham M; Lebret T; Mejean A; Escudier B
Lancet Oncol; 2015 Jun; 16(6):676-85. PubMed ID: 25979595
[TBL] [Abstract][Full Text] [Related]
26. Port site recurrence after laparoscopic radical nephrectomy: a case report.
Shimokihara K; Kawahara T; Takamoto D; Mochizuki T; Hattori Y; Teranishi JI; Miyoshi Y; Chiba S; Uemura H
J Med Case Rep; 2017 Jun; 11(1):151. PubMed ID: 28592262
[TBL] [Abstract][Full Text] [Related]
27. [Postoperative evaluation of renal cell carcinoma in the abdominal computed tomography].
Kurihara N; Tazawa S; Suzuki Y; Kato M
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Jun; 53(6):641-8. PubMed ID: 8337106
[TBL] [Abstract][Full Text] [Related]
28. Management of isolated renal fossa recurrence following radical nephrectomy.
Master VA; Gottschalk AR; Kane C; Carroll PR
J Urol; 2005 Aug; 174(2):473-7; discussion 477. PubMed ID: 16006867
[TBL] [Abstract][Full Text] [Related]
29. Combined robotic-assisted retroperitoneoscopic partial nephrectomy and extraperitoneal prostatectomy. First case reported.
Guttilla A; Crestani A; Zattoni F; Secco S; Dal Moro F; Valotto C; Zattoni F
Urologia; 2012; 79(1):62-4. PubMed ID: 22287267
[TBL] [Abstract][Full Text] [Related]
30. Commentary on "Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation." Kapur P, Peña-Llopis S, Christie A, Zhrebker L, Pavía-Jiménez A, Rathmell WK, Xie XJ, Brugarolas J. Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX. Lancet Oncol 2013; 14(2):159-67. [Epub 2013 Jan 16]. doi: 10.1016/S1470-2045(12)70584-3.
Boorjian S
Urol Oncol; 2014 Aug; 32(6):934-5. PubMed ID: 25087671
[TBL] [Abstract][Full Text] [Related]
31. [Cancer of the kidney in adults. Treatment of the localized stage].
Prog Urol; 1997 Nov; 7(5):843-57. PubMed ID: 9458482
[No Abstract] [Full Text] [Related]
32. [HIFU in urological oncology].
Thüroff S; Chaussy C
Urologe A; 2008 Apr; 47(4):431-2, 434-8, 440. PubMed ID: 18351319
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors in renal cell carcinoma.
Ljungberg B
Urologe A; 2004 Sep; 43 Suppl 3():S119-20. PubMed ID: 15179550
[No Abstract] [Full Text] [Related]
34. Functional and oncological outcomes of partial nephrectomy of solitary kidneys.
La Rochelle J; Shuch B; Riggs S; Liang LJ; Saadat A; Kabbinavar F; Pantuck A; Belldegrun A
J Urol; 2009 May; 181(5):2037-42; discussion 2043. PubMed ID: 19298974
[TBL] [Abstract][Full Text] [Related]
35. Clinical characteristics and outcomes of patients with recurrence 5 years after nephrectomy for localized renal cell carcinoma.
Adamy A; Chong KT; Chade D; Costaras J; Russo G; Kaag MG; Bernstein M; Motzer RJ; Russo P
J Urol; 2011 Feb; 185(2):433-8. PubMed ID: 21167521
[TBL] [Abstract][Full Text] [Related]
36. CD146 gene expression in clear cell renal cell carcinoma: a potential marker for prediction of early recurrence after nephrectomy.
Feng G; Fang F; Liu C; Zhang F; Huang H; Pu C
Int Urol Nephrol; 2012 Dec; 44(6):1663-9. PubMed ID: 22826148
[TBL] [Abstract][Full Text] [Related]
37. A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.
Klein EA; Yousefi K; Haddad Z; Choeurng V; Buerki C; Stephenson AJ; Li J; Kattan MW; Magi-Galluzzi C; Davicioni E
Eur Urol; 2015 Apr; 67(4):778-86. PubMed ID: 25466945
[TBL] [Abstract][Full Text] [Related]
38. Hilar location is an independent prognostic factor for recurrence in T1 renal cell carcinoma after nephrectomy.
Shim M; Song C; Park S; Kim A; Choi SK; Kim CS; Ahn H
Ann Surg Oncol; 2015 Jan; 22(1):344-50. PubMed ID: 25323469
[TBL] [Abstract][Full Text] [Related]
39. Renal cell carcinoma with inferior vena cava tumor thrombus and metastatic caval wall invasion.
Loh-Doyle JC; Patil MB; Daneshmand S
Urology; 2012 Feb; 79(2):e6-8. PubMed ID: 21724242
[TBL] [Abstract][Full Text] [Related]
40. Does the size of the surgical margin in partial nephrectomy for renal cell cancer really matter?
Sutherland SE; Resnick MI; Maclennan GT; Goldman HB
J Urol; 2002 Jan; 167(1):61-4. PubMed ID: 11743276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
